News and Announcements
REVIEW
Innovative strategies for modernizing evidence-based traditional Chinese medicine in Western health-care systems
Show Less
1
Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina,
United States of America
Submitted: 10 July 2024 | Accepted: 30 August 2024 | Published: 26 September 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract
Traditional Chinese medicine (TCM) faces significant challenges in modernization and integration into Western healthcare systems due to fundamental differences in diagnostic approaches, treatment targets, and underlying philosophies. Direct application of Western methodologies to TCM proves inadequate, necessitating a tailored approach that respects TCM’s unique aspects while ensuring scientific rigor. This article examines the challenges and opportunities in modernizing TCM, with a focus on its integration into Western healthcare systems governed by stringent regulatory frameworks such as those of the Food and Drug Administration in the US. It explores innovative strategies, such as using composite hypotheses in clinical trials to align evaluation criteria with TCM’s holistic approach and strategically using real-world data and evidence to enhance regulatory submissions. The proposed methodologies offer novel ways to bridge the divide between TCM and Western medicine, potentially transforming policy and practice in global healthcare systems. By adopting an approach that respects the unique aspects of TCM while ensuring scientific rigor, successful integration into Western health-care systems could be achieved, leveraging TCM’s potential benefits for patient care.
Keywords
Traditional Chinese medicine
Clinical development
Integrative medicine
Traditional Chinese medicine modernization
Funding
None.
Conflict of interest
The authors declare that they have no competing interests.
References
- Liu S, Matsuo T, Matsuo C, Abe T. Traditional Chinese medicines and prescriptions brought from China to Japan by a Monk (Jianzhen, Japanese: Ganjin): A historical review. Compounds. 2022;2:267-284. doi: 10.3390/compounds2040022
- International Classification of Diseases (ICD). Available from: https://www.who.int/standards/classifications/ classification-of-diseases [Last accessed on 2024 Sep 18].
- Lam WC, Lyu A, Bian Z. ICD-11: Impact on traditional Chinese medicine and World Healthcare Systems. Pharm Med. 2019;33(5):373-377. doi: 10.1007/s40290-019-00295-y
- Xin Y, Dai YY, Zhang XW, et al. A brief discussion on evidence-based clinical research of traditional Chinese medicine. Ann Palliat Med. 2021;10(12):12937-12944. doi: 10.21037/apm-20-697
- He J, Hou XY. The potential contributions of traditional Chinese medicine to emergency medicine. World J Emerg Med. 2013;4(2):92-97. doi: 10.5847/wjem.j.issn.1920-8642.2013.02.002
- De Felipe ÍO. The universality of science and traditional Chinese medicine: A philosophical survey. Sci Educ (Dordr). 2021;30(6):1353-1370. doi: 10.1007/s11191-021-00249-4
- Zhao C, Liu Z, Lin J, Wang YP, Wang YP, Shang HC. Standardizing individualized efficacy evaluation to optimize evidence-using pattern in traditional Chinese medicine--Preliminarily establishing traditional Chinese medicine evidence-based case reporting system. World J Tradit Chin Med. 2016;2(4):49-54. doi: 10.15806/j.issn.2311-8571.2016.0012
- Improving Diagnosis in Health Care - NCBI Bookshelf. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK338596 [Last accessed on 2024 Sep 18].
- Matos LC, Machado JP, Monteiro FJ, Greten HJ. Understanding traditional Chinese medicine therapeutics: An overview of the basics and clinical applications. Healthcare (Basel). 2021;9(3):257. doi: 10.3390/healthcare9030257
- Johnson AJ. Chinese Medical Qigong Therapy: A Comprehensive Clinical Guide. Available from: https://www. yumpu.com/en/document/view/63534342/chinese-medical-qigong-therapy-a-comprehensive-clinical-guide-by-jerry-alan-johnson-z-liborg [Last accessed on 2024 Sep 18].
- Griffith DM. Precision medicine approaches to health disparities research. Ethn Dis. 2020;30(Suppl 1):129-134. doi: 10.18865/ed.30.S1.129
- Food and Drug Administration. Botanical Drug Development Guidance for Industry. Maryland: Food and Drug Administration; 2016.
- U.S. Department of Health and Human Services. Guidance for Industry: Botanical Drug Products. Food and Drug Administration. 2004. Available from: http://www.fda.gov/ cder/guidance/4592fnl.htm [Last accessed on 2024 Sep 22].
- Krumholz HM, Ross JS, Presler AH, Egilman DS. What have we learnt from Vioxx? BMJ. 2007;334(7585):120-123. doi: 10.1136/bmj.39024.487720.68
- Shao J, Chow SC. Reproducibility probability in clinical trials. Stat Med. 2002;21(12):1727-1742. doi: 10.1002/sim.1177
- Zhou Y, Yang J, He Y, et al. Characteristic analysis of clinical trials for new traditional Chinese medicines in Mainland China from 2013 to 2021. Front Med (Lausanne). 2022;9:1008683. doi: 10.3389/fmed.2022.1008683
- Zhang M, Liu Y, Xu M, et al. Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study. Sci Rep. 2019;9(1):4545. doi: 10.1038/s41598-019-41118-z
- Wanga J, Xu C, Wong YK, et al. Artemisinin, the magic drug discovered from traditional Chinese medicine. Engineering. 2019;5:32-39. doi: 10.1016/j.eng.2018.11.011
- Tu Y. Artemisinin-A gift from traditional Chinese medicine to the world (nobel lecture). Angew Chem Int Ed Engl. 2016;55(35):10210-10226. doi: 10.1002/anie.201601967
- Li X, Zhang Y, Wang Y, et al. The mechanisms of traditional Chinese medicine underlying the prevention and treatment of Parkinson’s disease. Front Pharmacol. 2017;8:634. doi: 10.3389/fphar.2017.00634
- Chow SC. Innovative thinking for rare diseases drug development. Am J Biomed Sci Res. 2020;7(3):292-296. doi: 10.34297/AJBSR.2020.07.001159
- Chow SC, Song F. Statistical considerations for traditional Chinese medicine clinical trials. J Case Stud. 2015;4:134-142.
- Fai CK, De Qi G, Wei DA, Chung LP. Placebo preparation for the proper clinical trial of herbal medicine--requirements, verification and quality control. Recent Pat Inflamm Allergy Drug Discov. 2011;5(2):169-174. doi: 10.2174/187221311795399237
- Zhou L, Liu L, Liu X, et al. Systematic review and meta-analysis of the clinical efficacy and adverse effects of Chinese herbal decoction for the treatment of gout. PLoS One. 2014;9(1):e85008. doi: 10.1371/journal.pone.0085008
- Noyes J, Booth A, Moore G, Flemming K, Tunçalp Ö, Shakibazadeh E. Synthesising quantitative and qualitative evidence to inform guidelines on complex interventions: Clarifying the purposes, designs and outlining some methods. BMJ Glob Health. 2019;4:e000893. doi: 10.1136/bmjgh-2018-000893
- Hassan ZA, Schattner P, Mazza D. Doing a pilot study: Why is it essential? Malays Fam Physician. 2006;1(2-3):70-73.
- Vetter TR, Cubbin C. Psychometrics: Trust, but Verify. Anesth Analg. 2019;128(1):176-181. doi: 10.1213/ANE.0000000000003859
- Zhang YH, Lv J, Gao W, et al. Practitioners’ perspectives on evaluating treatment outcomes in traditional Chinese medicine. BMC Complement Altern Med. 2017;17:269. doi: 10.1186/s12906-017-1746-8
- Yu X, Wu S, Zhang J, et al. Developing TCM clinical practice guidelines: A comparison between traditional Chinese medicine and western medicine. Integr Med Res. 2023;12(2):100952. doi: 10.1016/j.imr.2023.100952
- Jin YH, Wang YP, Xie YL, et al. Research on the development methodology for clinical practice guidelines for organic integration of traditional Chinese and Western medicine. Mil Med Res. 2023;10(1):45. doi: 10.1186/s40779-023-00481-9